121. New Page 1 Dedicated to the life of a boy who passed away at the age of 11 after a heroic battle with NonHodgkins lymphoma. Includes photos of David and his art, a cat gallery, David's story, tributes and links. http://www2.netsell.com/schneider/

June 20th - 3rd Anniversary of David's passing - Forever in our hearts... Forever on our minds Welcome to our Memorial home page dedicated to our son and brother David. We are the Schneider family, living in Southern Ontario, Canada. Let us introduce ourselves. Joyce Schneider is a high school teacher of Drama and Performing Arts. Her spouse, Michael, is a teacher in the same school, head of the same department, and teaches English as well as Drama and Performing Arts. As you can see, we have absolutely nothing in common! Our beautiful daughter, Mary, is 16 years old. She is an accomplished dancer and baseball player, loves acting and singing, and is now finishing grade 11 at her mom and dad's school, and loves it. Our boy David passed away on June 20th 1998 after a long and struggle with non-Hodgkin’s’ lymphoma at the age of 11. This Web sight was intended in part to be a celebration of his life and we are grateful that he was able to participate in its creation. It is our David who greets you when you click on the " Cat Gallery " link, along with his beloved Butterscotch; it was recorded just 4 days prior to his passing. We have a separate page detailing David’s

122. Lymphoma lymphoma is a general term for a cancer that begins in the lymphatic system.There are two main types of lymphoma nonHodgkin lymphoma and Hodgkin lymphoma http://www.betterhealth.vic.gov.au/bhcv2/bhcarticles.nsf/pages/Lymphoma?OpenDocu

123. DermAtlas: Online Dermatology Image Library Dermatology Image,mycosis Fungoides, Skin biopsy showed changes typical of cutaneous Tcell lymphoma. Related Images,mycoses_fungoides_erythroderma_1_041001 http://dermatlas.med.jhmi.edu/derm/result.cfm?Diagnosis=196

124. Society : - Leukemia Provides general information about acute myelogenous leukemia touching upon such issues as risk factors, subtypes, diagnosis and treatment. http://www.leukemia-lymphoma.org/all_mat_toc.adp?item_id=3113

125. DermAtlas: Online Dermatology Image Library Dermatology Image,lymphoma,lymphomat DermAtlas Dermatology Images mycosis fungoides,lymphomatoidpapulosis,lymphoma,lymphoma,lymphoma,lymphoma,lymphoma,lymphoma,lymphoma,lymphoma,lymphoma http://dermatlas.med.jhmi.edu/derm/result.cfm?Diagnosis=760246814

126. Lrpfoundation Nonprofit assists patients and families with leukemia, lymphoma and other blood-related cancers. Located in Brentwood, Tennessee. http://lrpfoundation.org

Lisa and Chloe - April 2001 Lisa Ross Parker - Journal Entry - August 24th, 2001 Providing support for families touched by cancer Assisting animal welfare organizations WHO WE ARE Lisa's Story Our People WHAT WE DO ... CONTRIBUTE This Foundation is affiliated with the National Heritage Foundation

127. Latest Lymphoma Treatments Cancer Group Institute provides the latest information on the most effectivetraditional and alternative cancer treatments available. http://www.cancergroup.com/em36.html

L Y M P H O M A The human immune system is a fascinating network which protects us from all sorts of invading germs and parasites. It is composed of special bean-sized glands, called "lymph nodes," which filter the blood and destroy foreign invaders. These lymph nodes are connected to each other through an elaborate closed "circulation system" which eventually returns the purified lymph fluid to the bloodstream. Specific immune cells, called "lymphocytes," are contained within the lymph nodes, and also within the skin, tonsils, spleen, liver and intestines to quickly recognize and react to invading germs. Without this lymph system, we would soon die of overwhelming infection. A complex variety of cancers can arise within this system, called "lymphomas." Like any cancer, lymphoma starts from just one cell. Some lymphomas are "indolent," which means the patient can live for many years without any treatment at all. Others are very "aggressive," and among the most deadly cancers known. Just as their are many types of lymphomas, many treatment strategies have been researched. If a person develops lymphoma, it is critical to get prompt diagnosis and proper treatment; this can literally make the difference between life and death.

128. Introduction: Lymphoma - WrongDiagnosis.com Introduction to lymphoma as a medical condition including symptoms, diagnosis,misdiagnosis, treatment, prevention, and prognosis. http://www.wrongdiagnosis.com/l/lymphoma/intro.htm

Home Symptoms Diseases Risks ... Diseases Search our medical database Subscribe to our free Newsletter sample Send this page to a friend Condition Lists By Organ By Symptom By Class By Prevalence ... List A-Z Current chapter: Lymphoma Next sections Basic Summary for Lymphoma Prevalence and Incidence of Lymphoma Prognosis of Lymphoma Types of Lymphoma ... Incidence of Types of Lymphoma Next chapters: Myeloma Melanoma Adenoma Lung cancer ... Feedback Introduction: Lymphoma Lymphoma: Cancer involving lymph nodes and the immune system. Researching symptoms of Lymphoma: Further information about the symptoms of Lymphoma is available including a list of symptoms of Lymphoma , other diseases that might have similar symptoms in differential diagnosis of Lymphoma , or alternatively return to research other symptoms in the symptom center Misdiagnosis and Lymphoma: Research more detailed information about misdiagnosis of Lymphoma underlying causes of Lymphoma (possibly misdiagnosed), or research misdiagnosis of other diseases Causes of Lymphoma: Research more detailed information about the causes of Lymphoma , other possibly hidden causes of Lymphoma , or other general information about Lymphoma Statistics and Lymphoma: Various sources and calculations are available in statistics about Lymphoma prevalence and incidence statistics for Lymphoma , and you can also research other medical statistics in our statistics center Contents for Lymphoma: Basic Summary for Lymphoma Prevalence and Incidence of Lymphoma Prognosis of Lymphoma Types of Lymphoma ... Diseases Did we miss something? Please provide

129. Non-Hodgkin's Lymphoma Cancer Treatment - Rituxan (Rituximab) - Healthcare Profe Information about NonHodgkin's lymphoma and Rituxan (Rituximab), the first U.S. approved monoclonal antibody cancer treatment to treat Non-Hodgkin's lymphoma. http://non-hodgkins-lymphoma.rituxan.com

FULL PRESCRIBING INFORMATION Professional Home Patients and Caregivers Site Search Site Map Product Information Product Information Home Product Summary Rituxan Timeline Clinical Experience Patient Materials Patient Materials Home The Discoveries Program Administrative Tear Pad Professional Resources Professional Resources Home Presentation Slide Kits NHL Classification Links Safety Profile Safety Profile Home Learn More... SM (Single Point of Contact) for the healthcare professional. SPOC delivers timely response, personal service, and accurate information about reimbursement. Go to www.spoconline.com now Rituxan is currently indicated for relapsed or refractory low-grade or follicular, CD20+, B-cell non-Hodgkin's lymphoma (NHL). The first monoclonal antibody therapy approved in the United States for the treatment of cancer, Rituxan has been used widely and studied extensively since its approval by the federal Food and Drug Administration in 1997. [1] Today, more than 540,000 patients globally have received Rituxan, and it is part of more than 200 completed, ongoing, or planned clinical trials. [1] Rituxan has recently received approval to be administered as either a 4-dose or an 8-dose weekly regimen, to be used in patients who have previously responded to Rituxan, and in patients who have bulky tumors (>10 cm). Learn More...

130. IngentaConnect Publication: Leukemia And Lymphoma Leukemia and lymphoma. ISSN 10428194. Taylor and Francis Ltd logo. PublisherTaylor and Francis Ltd. 46 issues are available electronically http://www.ingentaconnect.com/content/tandf/glal

Home About Ingenta Ingenta Labs Help For Publishers Why go online? Why choose IngentaConnect? Why choose CustomConnect? Access and authentication ... Contact us For Researchers About IngentaConnect Search and browse Publications available Accessing articles ... Register For Librarians Why choose IngentaConnect? Why choose IngentaConnect Premium? Activating Subscriptions Purchasing articles ... Browse Publications Leukemia and Lymphoma ISSN 1042-8194 Publisher: Taylor and Francis Ltd issues are available electronically Volume 46 Number 9, September 2005 Number 8, August 2005 Number 6, June 2005 Number 5, May 2005 ... Number 3, March 2004 Volume 45 Number 12, December 2004 Number 11, November 2004 Number 10, October 2004 Number 9, September 2004 ... Number 1, January 2004 Volume 44 Number 12, December 2003 Number 11, September 2003 Number 10, September 2003 Number 9, June 2003 ... Supplement 3, Supplement 3/November 2003 Volume 6 Number 1, 2003 Volume 43 Number 12, 1 January 2002 Number 11, 1 January 2002 Number 10, 1 January 2002 Number 9, 1 January 2002 ... Activate Personal Subscription Latest Issue Recent Issues Browse within: Terms and Conditions Page Help Quick Search Electronic content Fax/Ariel content Journal or book title Sign in: User name Password Remember me forgotten your password?

131. THE LYMPHOMA FOUNDATION -- WELCOME Nonprofit raises funds for patient care and cancer research. Located in New York City. http://www.LymphomaFoundation.org

THE LYMPHOMA FOUNDATION HOME SCIENTISTS RESEARCH EVENTS ... CONTACT US WELCOME TO THE LYMPHOMA FOUNDATION Members of the Board and Friends LYMPHOMA FOUNDATION NEWS NEW and NOTEWORTHY: Ask your doctor to check your LDL-Cholesterol. It is more important than your total cholesterol. New data indicates that the 'old' guidelines may have to be revised and your goal should be an LDL-Cholesterol of 70 (seventy) or lower. GO TO: UPDATE ON HEART and ARTERY CHANGES AFTER TREATMENT THE EIGHTH ANNUAL BRIAN ROONEY RUN/WALK TO RAISE FUNDS FOR CANCER RESEARCH WAS HELD IN CENTRAL PARK IN NEW YORK CITY ON SATURDAY MAY 21, 2005 AT 10AM This special event held each spring in memory of Brian, an avid runner, who died at the age of 32 from non-Hodgkin's lymphoma... has raised funds each year for the past eight years to support clinical and basic lymphoma research by Dr. Dennis Cooper, Yale University, Dr. Gerald Spangrude, University of Utah and Dr. John Leonard, Cornell University that resulted in adding important data regarding the basic nature of normal and abnormal lymphocytes, improvements in stem cell transplantation and the use of newly developed monoclonal antibodies to treat non-Hodgkin's lymphomas. ATTENTION WOMEN SURVIVORS OF HODGKIN'S DISEASE LOWER YOUR CHOLESTEROL LEVELS WITH STATIN MEDICATIONS: CHECK OUT RECENT DATA ON THE HEART PAGE SPECIAL JUNE 2005 MEETING THE MEMORIAL SLOAN KETTERING LYMPHOMA/HEMATOLOGY/ AND RADIATION THERAPY FELLOWS SEMINAR

132. Lymphoma Rescue MOPP Rescue Protocol for lymphoma. MOPP Stands for. M ustargen 3.0 mg/m2IV (reconstitute with 10ml of NaCl for final concentration of 1 mg/ml) http://www.vetmed.lsu.edu/oncology/lymphoma.htm

MOPP Rescue Protocol for Lymphoma MOPP Stands for: M ustargen 3.0 mg/m2 IV (reconstitute with 10ml of NaCl for final concentration of 1 mg/ml) O ncovin (Vincristine) 0.7 mg/m2 IV P rocarbazine (Matulane) 50 mg/m2 PO q 24hrs P rednisone 30 mg/m2 PO q 24hrs Protocol Schedule day 1: Mustargen and vincristine IV day 7: Mustargen and vincristine IV day 1 through 14: Matulane and prednisone PO rest days 15-28 Patients are rechecked on day 28, and the cycle is started again This is a rescue protocol, intended for use in animals that have failed more conventional chemotherapy regimens.

133. ADAP Drugs: Doxorubicin Used alone and in combination with other drugs for treatment of tumors including malignant lymphomas and leukemias.(Adriamycin) http://www.atdn.org/access/drugs/doxo.html

doxorubicin (Adriamycin) Drug description Doxorubicin is used alone and in combination with other drugs for treatment of tumors including malignant lymphomas and leukemias. A new liposomal version of this drug called Doxil has been recently approvedl as a Side effects This drug causes additive bone marrow depression in combination with other cancer treatments and radiation. It should not be given if you are pregnant or breast feeding. If there is liver impairment, dosage must be reduced, and if you have had previous radiation, your skin may be aggravated at the site. Hair loss is possible. The drug can make your urine appear red for 1-2 days. Risk of mouth inflammation is greatest 5-10 days after treatment and usually lasts 3-7 days. Dosage Doxorubicin is given intravenously. Dose for adults is 60-75 mg/m2 once in 21 days, or 30 mg/m2 daily for 3 days every four weeks. Total cumulative dose should not exceed 550 mg/m2 without monitoring for cardiac function. How long it may take to work The effectiveness of treatment can be seen by decrease in size or spread of malignancies in solid tumors, or improvement of hematologic status in leukemias. Managing side effects Notify your doctor promptly if you have fever, sore throat, signs of infection, bleeding gums, bruising, blood in stools or urine, and increased fatigue. Avoid crowds and persons with known infections. Use a soft toothbrush and electric razor and avoid falls. Do not drink alcoholic beverages or take drugs containing aspirin because these can cause gastric bleeding. Rinse your mouth with warm salt water after eating and drinking. Practice contraception during treatment and for at least 4 months after therapy is concluded. Notify your doctor immediately if you have irregular heart beat, shortness of breath, or swelling of legs. Tell your doctor if you get a skin irritation at the site of previous radiation therapy. Do not receive any vaccinations without discussing with your doctor.

134. NCCN Patient Guidelines Chronic Lymphocytic Leukemia/Small Lymphocytic lymphoma; Follicular lymphoma (Small or Mixed Cell); Gastric MALT lymphoma; Nongastric MALT lymphoma http://www.nccn.org/patients/patient_gls/_english/_non_hodgkins/contents.asp

Order your free NCCN Treatment Guidelines for Patients today Home Patients ... Help Decision Trees Chronic/Small Lymphocytic Follicular Gastric Malt Non Gastric Malt ... AIDS-Related B-Cell Non-Hodgkin's Lymphoma Version II, January 2004 Click here to begin Introduction Making Decisions about Non-Hodgkin's Lymphoma Treatment What Is Non-Hodgkin's Lymphoma? ... Glossary Work-Up (Evaluation) and Treatment Guidelines: Decision Trees Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Follicular Lymphoma - Grade 1 and 2 (Small or Mixed Cell) Gastric MALT Lymphoma ... NCCN Home Page

135. Lymphoma Foundation Of America - Lymphomahelp.org lymphoma Foundation of America is the national organization devoted solely tohelping lymphoma patients and their families. http://www.lymphomahelp.org/

Lymphoma Foundation of America is the national organization devoted solely to helping lymphoma patients and their families. We were founded in 1986 by people with lymphoma who came together to help each other recover from cancer. We organized the first lymphoma support group in the United States. We advocate your right to know the truth about the risks and benefits of cancer treatments – whether standard, experimental, or alternative. Lymphoma Foundation of America is an independent, nonprofit charitable organization. Our work is supported entirely by donations and gifts from individuals. We do not accept drug company or industry funding. We are dedicated to helping you find the best care available for your type of lymphoma. We offer support, experience, advice, and a helping hand. All programs and services are free. Whether you are a cancer patient, family member, or friend, you can be part of the healing process. The way you respond to a life-threatening illness is just as important as the treatments you receive and the doctors you choose. Lymphoma Foundation of America is listed with the U.S. government’s cancer information hotline, 1-800-4-CANCER, a service of the National Cancer Institute.

136. Leukeran Online, Description, Chemistry, Ingredients - Chlorambucil - RxList Mon with links to full prescribing information for this alkylating agent of the nitrogen mustard type indicated in the treatment of chronic lymphatic (lymphocytic) leukemia, malignant lymphomas including lymphosarcoma, giant follicular lymphoma, and Hodgkin's disease....... http://www.rxlist.com/cgi/generic2/leukeran.htm

document.writeln(''); document.writeln(''); Chlorambucil document.writeln(''); document.writeln(''); Company Issues Pacemaker Malfunction Warning Deaths Seen With Fentanyl Narcotic Pain Patch FDA Reviews Adult Antidepressant-Suicide Link (chlorambucil) Tablets WARNING LEUKERAN (chlorambucil) can severely suppress bone marrow function. Chlorambucil is a carcinogen in humans. Chlorambucil is probably mutagenic and teratogenic in humans. Chlorambucil produces human infertility (see WARNINGS and PRECAUTIONS DESCRIPTION LEUKERAN (chlorambucil) was first synthesized by Everett et al. It is a bifunctional alkylating agent of the nitrogen mustard type that has been found active against selected human neoplastic diseases. Chlorambucil is known chemically as 4-[bis(2chlorethyl)amino]benzenebutanoic acid and has the following structural formula: Chlorambucil hydrolyzes in water and has a pKa of 5.8. LEUKERAN (chlorambucil) is available in tablet form for oral administration. Each sugar-coated tablet contains 2

137. Burkitt's Lymphoma Burkitt s lymphoma is a solid tumor of B lymphocytes, the lymphocytes that theimmune In most (approximately 90%) of the cases of Burkitt s lymphoma, http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/B/BurkittLymphoma.html

Burkitt's Lymphoma Burkitt's lymphoma is a solid tumor of B lymphocytes , the lymphocytes that the immune system uses to make antibodies . The genes for making antibodies are located on chromosomes (the heavy [H] chains), (kappa light chains), and (lambda light chains). These genes are expressed only in B lymphocytes because only B cells have the necessary transcription factors for the promoters and enhancers needed to turn these antibody genes " on In most (approximately 90%) of the cases of Burkitt's lymphoma, a reciprocal translocation has moved the proto-oncogene c- myc from its normal position on chromosome to a location close to the enhancers of the antibody heavy chain genes on chromosome In all the other cases, c- myc has been translocated close to the antibody genes on chromosome 2 or 22. In every case, c- myc now finds itself in a region of vigorous gene transcription, and it may simply be the overproduction of the c-myc product (a transcription factor essential for mitosis of mammalian cells) that turns the lymphocyte cancerous. Uncontrolled mitosis of this cell results in a clone of cancer cells, Burkitt's lymphoma. Many other human cancers involve chromosome aberrations, such as translocations, at the loci of known proto-oncogenes.

138. AIDS Fact Sheet: Lymphoma A description of the opportunistic infection NonHodgkin s lymphoma (NHL),including symptoms, diagnosis, prevention and treatment. http://www.aids.org/factSheets/512-Lymphoma.html

Information FactSheets Lymphoma WHAT IS LYMPHOMA? HOW IS NHL DIAGNOSED? WHAT CAUSES NHL? HOW IS NHL TREATED? ... THE BOTTOM LINE WHAT IS LYMPHOMA? Lymphoma is a cancer of white blood cells called B-lymphocytes. They multiply rapidly and form tumors. Lymphoma of the brain or spinal cord is called central nervous system lymphoma. AIDS-related lymphoma is sometimes called Non-Hodgkin's Lymphoma (NHL). In 1985, the Centers for Disease Control added NHL to the list of diseases that define AIDS. Hodgkin's Disease, another type of lymphoma, is rare in people with HIV. The longer you live with a suppressed immune system, the higher the risk of NHL. It can occur even with a high CD4 count. It can be serious and fatal, sometimes within a year. Combination antiviral therapy cut the rates of most opportunistic infections by about 80%. At first, this did not appear to be true for NHL. However, newer studies show a decrease of about 50% in NHL rates, especially CNS lymphoma. NHL still accounts for the deaths of about 20% of people with HIV. Approximately 10% of peole with HIV may eventually develop NHL. HOW IS NHL DIAGNOSED?

139. Welcome To Introna.com Official Pharmaceutical website for this medication used in the treatment of malignant melanoma, hepatitis C, hepatitis B, nonHodgkin's lymphoma, hairy cell leukemia, condylomata acuminata, and AIDS-related Kaposi's sarcoma. http://www.introna.com

Hot links Indications... introna.com... About Intron A Therapy... Melanoma... If you're reading this, it's probably because your doctor has prescribed treatment with INTRON A (Interferon alfa-2b, recombinant) for Injection therapy. INTRON A (Interferon alfa-2b, recombinant) for Injection is an interferon used as a frontline treatment for a number of indications. more... INTRON A therapy has been approved for use in the treatment of malignant melanoma hairy cell leukemia chronic hepatitis B chronic hepatitis C ... follicular (non-Hodgkin's) lymphoma , and AIDS-related Kaposi's sarcoma For more on indications, dosages, and other prescription information, click on INTRON A Prescribing Information There are a number of possible side effects associated with INTRON A therapy injections. We will address each of them, and what to do about them, in detail. more... Someone you're close to has just begun INTRON A therapy for treatment of a serious illness. If you're reading this, you're probably one of the people who has been asked to help. more...

140. The Wellness Community-Frankly Speaking About Lymphoma This information has been created for people with lymphoma and their families as Also, knowledge about lymphoma and treatment is in a continual state of http://www.thewellnesscommunity.org/programs/frankly/lymphoma/

Home Support Group Log On Help document.write(menu); Frankly Speaking About Lymphoma Made possible through unrestricted educational grants from and Frankly Speaking About Lymphoma contains 7 separate sections, each focusing on a different aspect of cancer experience. The sections and a description of their contents include: Being Patient Active with Lymphoma What is Patient Active? Your Treatment Team The Physician-Patient Relationship Actions People with Lymphoma Can Take Finding a Lymphoma Specialist Understanding Lymphoma Basic Facts about Lymphoma Hodgkin's Disease Indolent Non-Hodgkin's Lymphoma Aggressive Non-Hodgkin's Lymphoma Describing and Classifying Lymphoma Treatment For Lymphoma Overview of Lymphoma Treatment Treating Hodgkin's Disease Treating Indolent Non-Hodgkin's Lymphoma Treating Aggressive Non-Hodgkin's Lymphoma What is a Clinical Trial? Why Consider a Clinical Trial? Finding a Clinical Trial Making the Mind-Body Connection Integrating Mind-Body Practices into Lymphoma Treatment Mind-Body Practice Exercises Managing the Personal Impact Psychological Concerns The Value of Emotional Support Spiritual Issues Valuable Resources National Organizations Books, Pamphlets, Periodicals and Tapes

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Page 7     121-140 of 180    Back | 1  | 2  | 3  | 4  | 5  | 6  | 7  | 8  | 9  | Next 20